Ambea resolves on repurchase of own shares

Report this content

The board of directors in Ambea AB (publ) has resolved to repurchase a maximum of 3 000 000 own shares on Nasdaq Stockholm during the period until the time of the company’s Annual General Meeting 2024. The resolution is made by virtue of the authorisation from the Annual General Meeting 2023 to repurchase own shares.

The objective of the share repurchase program is to optimise the company’s capital structure and contribute to increased shareholder value.
The share repurchase program will be managed by a credit institution that will act in accordance with instructions from the company. 

The share repurchase program resolved by the board of directors is subject to the following terms:

  1. Repurchases may only be effected on Nasdaq Stockholm in accordance with Nasdaq Stockholm’s Rulebook for Issuers of Shares (below the “Rulebook”).
     
  2. Repurchases may be made on one or several occasions until the time of the company’s Annual General Meeting 2024. 
     
  3. Repurchases may only be effected at a price per share within the prevailing band of prices applying on Nasdaq Stockholm from time to time. The range of prices pertains to the range between the highest purchase price and the lowest selling price disseminated by Nasdaq Stockholm from time to time.
     
  4. Repurchases may only be effected in accordance with the restrictions regarding volume for acquisitions of own shares stated in the Rulebook.
     
  5. A maximum of 3 000 000 shares may be repurchased. The company’s holding of own shares may not at any time exceed 10 per cent of the total number of shares in the company.
     
  6. Repurchases may also be made by way of block trades in accordance with applicable rules.

The total number of shares in Ambea is 89 562 698. At the time of this press release the company holds 0 own shares.

For more information, contact:

Susanne Vogt, head of IR
E-mail: ir@ambea.se

Ambea press contact
Telephone: +46 (0)10 33 00 501
E-mail: press@ambea.se

Ambea is Scandinavia’s leading competence -based care company. Ambea has 31,000 employees who are creating a good life for every care receiver in our 950 units. We aim to be the quality leader in all that we do and our vision is to make the world a better place, one person at a time. Ambeas head office is located in Solna, Sweden. Ambea is listed on Nasdaq Stockholm.